Menu
Washington DC
DC Dispensaries
DC Weed Reviews
DC Medical Reviews
DC Delivery Services
How to Buy Weed in DC
I-71 Information
History of Legal Weed in DC
DC Medical Marijuana Guide
Virginia
Find the BEST weed in...
Pentagon sued over cannabis questions for military contractors (Newsletter: July 4, 2025)
Jul 4, 2025
Tom Angell
Marijuana Moment
*WI GOP legislature rejects marijuana amendments; CA ending cannabis
testing for prison guards; Researchers slam Schedule I restrictions*
Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.
Email address:
Leave this field empty if you're human:
*Your support makes Marijuana Moment possible…*
*Your good deed for the day:* donate to an independent publisher like
Marijuana Moment and ensure that as many voters as possible have access to
the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
*/ TOP THINGS TO KNOW*
The Wisconsin Senate and Assembly rejected amendments to restore marijuana
legalization provisions in the budget that were included by Gov. Tony Evers
(D) but stripped out by the legislature’s Republican majority.
The California Senate Budget and Fiscal Review Committee approved a bill to
ratify a labor agreement ending random drug tests for marijuana among most
correctional officers in the state’s prison system.
A Department of Defense contractor is suing the federal government,
claiming that questions about past marijuana use during a security
clearance process violated his Fifth Amendment right against
self-incrimination.
Federally funded scientists argue in a new journal article that marijuana’s
Schedule I status “traps researchers in a paradox” because “proving medical
value requires studies, yet studies are heavily restricted” due to ongoing
prohibition.
Former New York Office of Cannabis Management Official Damian Fagon argues
in a new Marijuana Moment op-ed that a recent cannabis poll from a “Big
Tobacco”-backed group is “a thinly veiled attempt to persuade policymakers
to take a broadly popular issue in a less popular direction.”
*/ FEDERAL*
The Drug Enforcement Administration published a list of chemical
preparations that it has determined are exempt from certain provisions of
the Controlled Substances Act.
Rep. Dan Crenshw (R-TX) tweeted about Health and Human Services Secretary
Robert F. Kennedy Jr.’s commitment to advancing psychedelics therapy
research, saying, “This is the kind of urgency we need. I passed a law in
2022 to fund the first federal trials into psychedelic therapies because
too many of my teammates never made it home in one piece. Veteran suicide
is a national crisis and this could be a breakthrough. Really appreciate
@SecKennedy building on that momentum.”
*/ STATES*
Former Vermont Gov. Peter Shumlin (D) is joining the board of directors of
FLUENT Corp.
A Pennsylvania senator tweeted, “I’ve introduced SB 49 to create the PA
Cannabis Control Board, bringing consistent oversight to medical marijuana
& setting safety standards for unregulated hemp products. Time for
transparency & stronger protections for all Pennsylvanians.”
Rhode Island regulators asked the U.S. Court of Appeals for the First
Circuit to uphold the dismissal of a lawsuit challenging the state’s
marijuana rules.
Maryland regulators adopted changes to rules for the cannabis social equity
partnership grant program.
Missouri regulators launched a marijuana product sampling and testing
initiative.
California regulators sent guidance on the form that cannabis products must
be in for compliance testing.
Minnesota regulators posted guidance about transitioning between hemp and
marijuana product regulatory frameworks.
Michigan regulators published updated disciplinary guidelines for marijuana
businesses.
Kentucky regulators published guidance on the medical cannabis card
application process.
Colorado regulators published a bulletin on when to report psychedelic
adverse events.
*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*
*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*
*/ INTERNATIONAL*
The UK Food Standards Agency published updated guidance about CBD products.
*/ SCIENCE & HEALTH*
A review concluded that “synthetic cannabinoid agonists display significant
potential in targeting CB1 and CB2 receptors to inhibit tumor proliferation
and promote apoptosis across various cancer types.”
A review concluded that “compared to conventional treatments, psychedelics
offer faster onset, durable effects, and possible disease-modifying
properties, making them promising candidates for future neurotherapeutics.”
*/ BUSINESS*
AYR Wellness Inc. announced it did not make an interest payment due on June
30 in connection with outstanding senior notes.
Washington, D.C. dispensaries sold $5.8 million worth of medical cannabis
in May.
*/ CULTURE*
Mike Tyson discussed his use of cannabis.
*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.
Email address:
Leave this field empty if you're human:
The post Pentagon sued over cannabis questions for military contractors
(Newsletter: July 4, 2025) appeared first on Marijuana Moment.













